These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24780475)

  • 1. Nonextracorporeal methods for decreasing uremic solute concentration: a future way to go?
    Meijers B; Glorieux G; Poesen R; Bakker SJ
    Semin Nephrol; 2014 Mar; 34(2):228-43. PubMed ID: 24780475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing transporters to clear uremic toxins.
    Moe OW
    J Am Soc Nephrol; 2009 Dec; 20(12):2483-4. PubMed ID: 19926890
    [No Abstract]   [Full Text] [Related]  

  • 6. The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease.
    Koppe L; Fouque D; Soulage CO
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29652797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut-kidney axis.
    Evenepoel P; Poesen R; Meijers B
    Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota and prebiotics modulation of uremic toxin generation.
    Koppe L; Fouque D
    Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics.
    Vitetta L; Gobe G
    Mol Nutr Food Res; 2013 May; 57(5):824-32. PubMed ID: 23450842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut: the forgotten organ in uremia?
    Schepers E; Glorieux G; Vanholder R
    Blood Purif; 2010; 29(2):130-6. PubMed ID: 20093818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease and the gut microbiome.
    Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Kidney-Gut Axis: Implications for Nutrition Care.
    Rossi M; Johnson DW; Campbell KL
    J Ren Nutr; 2015 Sep; 25(5):399-403. PubMed ID: 25812908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapeutic perspectives on protein-bound uremic toxins in chronic kidney disease.
    Malyszko J
    Expert Opin Ther Targets; 2014 Feb; 18(2):109-13. PubMed ID: 24283253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota as a Source of Uremic Toxins.
    Popkov VA; Zharikova AA; Demchenko EA; Andrianova NV; Zorov DB; Plotnikov EY
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport.
    Yeung CK; Shen DD; Thummel KE; Himmelfarb J
    Kidney Int; 2014 Mar; 85(3):522-8. PubMed ID: 24132209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
    Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
    Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid metabolism in the chronically uremic rat.
    Swendseid ME; Wang M; Vyhmeister I; Chan W; Siassi F; Tam CF; Kopple JD
    Clin Nephrol; 1975 Jun; 3(6):240-6. PubMed ID: 237643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the intestinal microbiota in uremic solute accumulation: a focus on sulfur compounds.
    Perna AF; Glorieux G; Zacchia M; Trepiccione F; Capolongo G; Vigorito C; Anishchenko E; Ingrosso D
    J Nephrol; 2019 Oct; 32(5):733-740. PubMed ID: 30673975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nitrogen removal from the intestinal tract of uraemic patients.
    Man NK; Drueke T; Paris J; Monteverde CE; Nucete MR; Zingraff J; Jungers P
    Proc Eur Dial Transplant Assoc; 1973; 10(0):143-51. PubMed ID: 4802503
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD.
    Kortman GAM; Reijnders D; Swinkels DW
    Hemodial Int; 2017 Jun; 21 Suppl 1():S28-S36. PubMed ID: 28328083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.